CRISPR activation and interference screens decode stimulation responses in primary human T cells

Science. 2022 Feb 4;375(6580):eabj4008. doi: 10.1126/science.abj4008. Epub 2022 Feb 4.

Abstract

Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity, immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine regulators requires both loss-of-function and gain-of-function studies, which have been challenging in primary human cells. We now report genome-wide CRISPR activation (CRISPRa) and interference (CRISPRi) screens in primary human T cells to identify gene networks controlling interleukin-2 (IL-2) and interferon-γ (IFN-γ) production. Arrayed CRISPRa confirmed key hits and enabled multiplexed secretome characterization, revealing reshaped cytokine responses. Coupling CRISPRa screening with single-cell RNA sequencing enabled deep molecular characterization of screen hits, revealing how perturbations tuned T cell activation and promoted cell states characterized by distinct cytokine expression profiles. These screens reveal genes that reprogram critical immune cell functions, which could inform the design of immunotherapies.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • CRISPR-Associated Protein 9 / genetics
  • CRISPR-Associated Protein 9 / metabolism*
  • CRISPR-Cas Systems*
  • Cell Line
  • Cells, Cultured
  • Gene Expression Regulation
  • Gene Regulatory Networks*
  • Genome, Human
  • Humans
  • Interferon-gamma / biosynthesis*
  • Interferon-gamma / genetics
  • Interleukin-2 / biosynthesis*
  • Interleukin-2 / genetics
  • Lymphocyte Activation*
  • NF-kappa B / metabolism
  • RNA-Seq
  • Signal Transduction
  • Single-Cell Analysis
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism

Substances

  • IL2 protein, human
  • Interleukin-2
  • NF-kappa B
  • Interferon-gamma
  • CRISPR-Associated Protein 9